32
TITLE: Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel COMT inhibitor, during the first administration to healthy male subjects  Full Text
AUTHORS: Nunes, T; F Rocha; Pinto, R ; Machado, R; Wright, L; Falcao, A; Almeida, L; Soares da Silva, P ;
PUBLISHED: 2012, SOURCE: 16th Congress of the European-Federation-of-Neurological-Societies (EFNS) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 19
INDEXED IN: WOS
IN MY: ORCID
34
TITLE: Evaluation of Eslicarbazepine Acetate on Cardiac Repolarization in a Thorough QT/QTc Study
AUTHORS: Vaz da Silva, M ; Nunes, T; Almeida, L; Gutierrez, MJ; Litwin, JS; Soares da Silva, P ;
PUBLISHED: 2012, SOURCE: JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 52, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 20
IN MY: ORCID
37
39
TITLE: Effect of food on the pharmacokinetic profile of etamicastat (BIA 5-453)  Full Text
AUTHORS: Vaz Da Silva, M ; Nunes, T; Rocha, JF; Falcao, A ; Almeida, L; Soares Da Silva, P ;
PUBLISHED: 2011, SOURCE: Drugs in R and D, VOLUME: 11, ISSUE: 2
INDEXED IN: Scopus CrossRef: 7
IN MY: ORCID
40
TITLE: Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy. Long-Term Treatment with ESL  Full Text
AUTHORS: Halasz, P; Cramer, JA; Hodoba, D; Czlonkowska, A; Guekht, A; Maia, J; Elger, C; Almeida, L; Soares da Silva, P ;
PUBLISHED: 2010, SOURCE: EPILEPSIA, VOLUME: 51, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 84
IN MY: ORCID
Page 4 of 10. Total results: 94.